DK1054666T3 - Væskeformig farmaceutisk formulering, der indeholder zotepin - Google Patents

Væskeformig farmaceutisk formulering, der indeholder zotepin

Info

Publication number
DK1054666T3
DK1054666T3 DK99907436T DK99907436T DK1054666T3 DK 1054666 T3 DK1054666 T3 DK 1054666T3 DK 99907436 T DK99907436 T DK 99907436T DK 99907436 T DK99907436 T DK 99907436T DK 1054666 T3 DK1054666 T3 DK 1054666T3
Authority
DK
Denmark
Prior art keywords
zotepin
pharmaceutical formulation
formulation containing
liquid pharmaceutical
liquid
Prior art date
Application number
DK99907436T
Other languages
English (en)
Inventor
Ann Margaret Dyer
Alan Smith
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Application granted granted Critical
Publication of DK1054666T3 publication Critical patent/DK1054666T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK99907436T 1998-02-07 1999-01-27 Væskeformig farmaceutisk formulering, der indeholder zotepin DK1054666T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9802617.2A GB9802617D0 (en) 1998-02-07 1998-02-07 Pharmaceutical formulation
PCT/EP1999/000533 WO1999039709A1 (en) 1998-02-07 1999-01-27 Liquid pharmaceutical formulation containing zotepine

Publications (1)

Publication Number Publication Date
DK1054666T3 true DK1054666T3 (da) 2003-03-17

Family

ID=10826622

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99907436T DK1054666T3 (da) 1998-02-07 1999-01-27 Væskeformig farmaceutisk formulering, der indeholder zotepin

Country Status (25)

Country Link
US (1) US6239165B1 (da)
EP (1) EP1054666B1 (da)
JP (1) JP2002502818A (da)
KR (1) KR20010040717A (da)
AR (1) AR018062A1 (da)
AT (1) ATE227988T1 (da)
AU (1) AU2720099A (da)
BG (1) BG104682A (da)
BR (1) BR9907644A (da)
CA (1) CA2320475A1 (da)
CO (1) CO4970815A1 (da)
CZ (1) CZ291975B6 (da)
DE (1) DE69904021T2 (da)
DK (1) DK1054666T3 (da)
ES (1) ES2188135T3 (da)
GB (1) GB9802617D0 (da)
HK (1) HK1033088A1 (da)
HR (1) HRP20000579A2 (da)
HU (1) HUP0100769A3 (da)
PL (1) PL342213A1 (da)
PT (1) PT1054666E (da)
SK (1) SK11472000A3 (da)
TR (1) TR200002288T2 (da)
WO (1) WO1999039709A1 (da)
ZA (1) ZA99918B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006032426A1 (de) * 2006-07-13 2008-01-17 Neuraxpharm Arzneimittel Gmbh U. Co. Kg Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung
DE102006032427A1 (de) * 2006-07-13 2008-01-17 Neuraxpharm Arzneimittel Gmbh U. Co. Kg Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1247067A (en) * 1968-02-16 1971-09-22 Fujisawa Pharmaceutical Co Tricyclic enol ether compounds and the preparation thereof
JPS5191315A (ja) * 1975-02-06 1976-08-10 Anteinaensantoruperizonshirotsupunoseizoho
JPS5852220A (ja) * 1981-09-24 1983-03-28 Fujisawa Pharmaceut Co Ltd 血清尿酸値低下剤
JPH07116039B2 (ja) * 1988-01-11 1995-12-13 オール薬品工業株式会社 安定な塩酸トリメトキノール内用液剤
ZA90341B (en) * 1989-01-23 1990-10-31 Merrell Dow Pharma Liquid pharmaceutical composition for piperidinoalkanol derivatives
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations
JPH0827034A (ja) * 1994-07-14 1996-01-30 Nikken Chem Co Ltd エリスリトール含有内用液剤
EP0733368A1 (en) * 1995-03-24 1996-09-25 Eli Lilly And Company Granule fomulation for olanzapine
GB9526264D0 (en) * 1995-12-21 1996-02-21 Knoll Ag Medical treatment
JPH09286723A (ja) * 1996-04-19 1997-11-04 Takeda Chem Ind Ltd 改善された経口液剤

Also Published As

Publication number Publication date
AR018062A1 (es) 2001-10-31
CO4970815A1 (es) 2000-11-07
PL342213A1 (en) 2001-05-21
HK1033088A1 (en) 2001-08-17
AU2720099A (en) 1999-08-23
HUP0100769A2 (hu) 2001-12-28
PT1054666E (pt) 2003-03-31
EP1054666B1 (en) 2002-11-20
DE69904021T2 (de) 2003-04-30
DE69904021D1 (de) 2003-01-02
TR200002288T2 (tr) 2000-12-21
HUP0100769A3 (en) 2002-04-29
HRP20000579A2 (en) 2001-04-30
JP2002502818A (ja) 2002-01-29
CZ291975B6 (cs) 2003-06-18
CA2320475A1 (en) 1999-08-12
ATE227988T1 (de) 2002-12-15
GB9802617D0 (en) 1998-04-01
ES2188135T3 (es) 2003-06-16
EP1054666A1 (en) 2000-11-29
SK11472000A3 (sk) 2001-08-06
KR20010040717A (ko) 2001-05-15
BG104682A (en) 2001-05-31
ZA99918B (en) 2000-08-07
BR9907644A (pt) 2000-11-14
WO1999039709A1 (en) 1999-08-12
US6239165B1 (en) 2001-05-29
CZ20002846A3 (cs) 2000-12-13

Similar Documents

Publication Publication Date Title
NO20012915D0 (no) Ny farmasöytisk formulering
PT853945E (pt) Formulacoes liquidas contendo gonadotrofina
NO20020086D0 (no) Smaksmaskerte farmasöytiske flytende formuleringer
DE69822346D1 (de) Flüssigkeitsverpackung
BR9810801B1 (pt) composição lìquida aquosa.
DK1073417T3 (da) Farmaceutisk aerosolformulering
TR199901077A3 (tr) Ispençiyari formülasyonlar.
DK1263720T3 (da) Azetidinderivater, fremstilling deraf samt farmaceutiske sammensætninger, der indeholder samme
FI991485A0 (fi) Uusi farmaseuttinen koostumus
ID27415A (id) Komposisi farmaseutik
ID29262A (id) Komposisi farmasi
ATE281074T1 (de) Flüssige pestizidzusammensetzung
ID27201A (id) Komposisi farmasi
PT966952E (pt) Produtos liquidos contendo eritritol
DE69821977D1 (de) Flüssige, insektizide aufgiessformulierung
DE60015536D1 (de) Flüssige herbizidzusammensetzung
DE69907628D1 (de) Flüssigkeitsspender
ID30032A (id) Formulasi farmasi
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
DE69910323D1 (de) Flüssigkeitsabgabevorrichtung
AR025867A1 (es) Formulacion portasdora farmaceutica
ID26215A (id) Komposisi farmasi
NO20004816D0 (no) Ny farmasøytisk formulering
DK1054666T3 (da) Væskeformig farmaceutisk formulering, der indeholder zotepin
DE69916615D1 (de) Flüssigformulierung